March/April 2016

Executives from GE Healthcare, McKesson, Merge Healthcare, Philips and Siemens Healthcare joined Cardiovascular Business for a candid discussion about cardiologists’ information technology concerns and questions.

Kathy Boyd David

For this issue, Cardiovascular Business invited executives from five cardiovascular IT companies to join us for an hour. They tackled every question we asked and more.

A disconnect between best care and what Medicare is willing to reimburse for it has put some electrophysiologists and their hospitals in a bind.

While mobile apps show promise to revolutionize healthcare delivery, they also pose important questions.

patient

Good outcomes in revascularizing high-risk, complex PCI patients start with careful patient selection. The secret to success in complete revascularization with Protected PCI involves some art, some science and begins with following proven protocols.

Will noninferior results be good enough to win over cardiologists and payers?

As the American College of Cardiology (ACC) prepares for its 65th Annual Scientific Sessions, to be held in Chicago, April 2-4, 2016, Program Chair Athena Poppas, MD, reflects on how today’s attendees learn and what they appreciate at in-person meetings. Here’s a preview of some ACC.16 highlights.

Cardiology Patient Visits With and Without a Scribe

Physicians and patients are seeing less of each other over the barrier of computer screens. Is hiring scribes the answer?

Gregory J. Dehmer, MD

A new program announced by the ACC will make it possible for the public to access data submitted by hospitals to the National Cardiovascular Data Registry.

Balancing needs, utilization and cost while improving patient care are central to the mission of the interventional cardiology team at Emory Saint Joseph’s Hospital in Atlanta.

AACVPR is working to redefine how cardiac rehabilitation is referred, provided and reimbursed.

Transcatheter aortic valve replacement (TAVR) is proving to be a disruptive technology, as cardiac surgeons and cardiologists join forces and combine resources to determine its ultimate utility.

How VIVA Physicians is working to answer questions about treatment of vascular disease.

Select an Issue
View the Digital Edition